RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q4 2025 vs. Q3 2025
How the institutions holding RAPT Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 65 | 1 | 106 | +42 |
| Shares | 16.6M | 16 | 30.3M | +13.7M (+82.7%) |
| Value | $428.0M | $405 | $1.02B | +$593.8M (+138.7%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (50)
Institutions that held RAPT Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (8)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| SummitTX Capital, L.P. | 91,912 | $2.37M |
| Ameriprise Financial Inc | 51,406 | $1.33M |
| Balyasny Asset Management LLC | 50,348 | $1.30M |
| Superstring Capital Management LP | 34,449 | $888.4K |
| Trustees of Columbia University in the City of New York | 9,172 | $236.5K |
| Russell Investments Group, Ltd. | 1,080 | $27.9K |
| Banque Cantonale Vaudoise | 154 | $7.00K |
| SRS Capital Advisors, Inc. | 1 | $25 |
Not filed for Q4 2025 yet (1)
Institutions that held RAPT Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Point72 (DIFC) Ltd | 16 | $405 |